Do you want to be part of an inclusive team that works to develop innovative therapies for patients? Every day, we are driven to develop and deliver innovative and effective new medicines to patients and physicians. If you want to be part of this exciting work, you belong at Astellas!
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the world. For more information on Astellas, please visit our website at www.astellas.com .

QUALIFICATIONS REQUIRED:

Bachelor’s Degree in Biology, Molecular Biology or other scientific discipline
Prior Diagnostic (CDx) / Medical Device & Pharma marketing experience within Oncology
Regional Diagnostic launch experience
Technical understanding of diagnostic technologies
7+ years experience in pharmaceutical and/or healthcare industry
Strategic thinking skills to create a robust business case, analyze commercial and business information and devise strategy.
Willingness to travel 10-15% of the time

PREFERRED SKILLS:

Advanced degree (Ph.D in Life Science, MBA, Medical, or Pharmacy)

PURPOSE & SCOPE:

The GBSM Precision Medicine Lead, Strategy (Global Brand Strategy & Marketing - GBSM) will be responsible for the development and implementation of the Global Precision Medicine Strategy.
This position will report directly into the Precision Medicine Strategic Lead – Global Brand Strategy and Marketing, and will work in close partnership with cross-functional partners including Medical & Development (M&D), Companion Diagnostic (CDx) Partners, Global Brand Marketing, Affiliate Marketing, Regulatory, Legal, Market Access and other functions to facilitate successful diagnostic launches.

RESPONSIBILITIES ARE BOTH GLOBAL AND REGIONAL:

Strategy Lead for Select Biomarkers / Indications – Develop and lead Precision Medicine Strategy for select biomarker programs (e.g. CLDN18.2 for Pancreatic Cancer & KRAS) including Commercial CDx partner evaluation, Precision Medicine (PM) strategic plan / iGBP, launch planning, core global materials, KEEs, Diagnostic Testing Education and coordination with other PM colleagues to ensure implementation and localization in key geographies
US Support: late-stage Biomarkers / Indications – oversee pull through of Precision Medicine launch/commercialization strategy including DTE, market research, ad boards, material development and MLR review
Global PM Above Brand Lead - CDx Partner commercial governance, cross-functional stakeholder management, Precision Medicine Enterprise strategy/metric development, diagnostic testing education (DTE) development process, Pathologist KEE strategy and Global channel strategy for affiliate adoption of Global diagnostic strategy

RESPONSIBILITIES:

Lead commercial assessment, recommendations for specific diagnostic opportunities and pull through of commercialization agreement deliverables/timing
Lead commercial evaluation of companion diagnostics platforms, actively seek new products/technologies, effectively partner and foster key collaboration with appropriate industry, academics, and government partners
Provide diagnostic leadership, support and expertise to Global and US Precision Medicine counterparts and cross-functional partners
Develop Precision Medicine strategy and corresponding marketing/operationalization plans to drive implementation for affiliates
Lead Diagnostic insight generation priorities working closely with Commercial Insights
Garner and incorporate Commercial Insights to Global Diagnostic strategy
Define precision medicine KPIs, scorecards and analyze performance of programs and select biomarkers / indications on an ongoing basis
Support and lead agency relationships, workflow, and related expense budgets to establish the DTE communication pillars, scientific narrative and messaging for select biomarkers / indications
Develop and manage Global Key External Expert (KEE) steering committee to gain insight and alignment on diagnostic strategy recommendations
Development, evolution and management of all aspects of the virtual pathology account manager program (vPAM) across tumor/test types to align with Global strategy, including pull through with other Global Precision Medicine leads based in the regions
Support US pull through of Global Precision Medicine strategy including DTE localization and market research, ad boards, material development and MLR review
Lead implementation and evolution of Enterprise Precision Medicine Ecosystem
Ensure adherence to Astellas policies relating to Ethics and Compliance standards and interactions with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and Patient Organizations (POs).